Clinical Trial: MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07548346) titled 'MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis' on April 16.

Brief Summary: REVIVE-CVST is a multicenter, prospective, randomized, open-label, blinded-endpoint (PROBE) trial evaluating whether early endovascular thrombectomy (EVT) combined with standard anticoagulation improves outcomes compared to anticoagulation alone in patients with severe cerebral venous sinus thrombosis (CVST).

The study targets adult patients (aged 18 years or older) presenting within 14 days of symptom onset with imaging-confirmed CVST and at least one severity marker, such as a Glasgow Coma Scale score of 14 or below, ...